Organization and Significant Accounting Policies (Details) - USD ($)			3 Months Ended				6 Months Ended
	Apr. 15, 2025	Mar. 06, 2024	Jun. 30, 2025	Mar. 31, 2025	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024	May 25, 2005
Organization and Significant Accounting Policies [Line Items]
Cash and cash equivalents			$ 600,000				$ 600,000
Accumulated deficit			(45,340,618)				(45,340,618)		$ (44,026,679)
Working capital deficit			2,500,000				2,500,000
Net loss			(528,367)	$ (785,572)	$ (1,438,130)	$ (955,892)	(1,313,939)	$ (2,394,022)
Cash flows from operating activities							233,258	$ (657,884)
Advanced additional amount			240,000				240,000
Aggregate working capital amount			$ 1,407,607				$ 1,407,607		$ 1,144,985
Reverse stock split		1-for-5
China Pharma [Member]
Organization and Significant Accounting Policies [Line Items]
Reverse stock split	1-for -10
Onny Investment Limited [Member]
Organization and Significant Accounting Policies [Line Items]
Ownership percentage			100.00%				100.00%
Hainan Helpson Medical & Biotechnology Co., Ltd [Member]
Organization and Significant Accounting Policies [Line Items]
Ownership percentage			100.00%				100.00%			100.00%
Share-Based Payment Arrangement, Option [Member]
Organization and Significant Accounting Policies [Line Items]
Potentially dilutive common shares (in Shares)							1,330	1,330